Jong Seog Ahn Selected Research

Jong Seog Ahn Research Topics

Disease

32	Neoplasms (Cancer) 05/2022 - 07/2003
11	Obesity 10/2009 - 02/2006
10	Type 2 Diabetes Mellitus (MODY) 10/2009 - 09/2005
5	Prostatic Neoplasms (Prostate Cancer) 09/2015 - 11/2006
3	Hypoxia (Hypoxemia) 12/2019 - 01/2017
3	Carcinogenesis 01/2018 - 03/2004
2	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 04/2012
2	Melanoma (Melanoma, Malignant) 04/2020 - 05/2014
2	Skin Neoplasms (Skin Cancer) 04/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2018 - 07/2010
2	Infections 01/2015 - 07/2014
2	Hepatocellular Carcinoma (Hepatoma) 05/2013 - 12/2011
2	Osteoporosis 02/2013 - 06/2012
2	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2008 - 08/2007
1	Brain Diseases (Brain Disorder) 01/2022
1	Neuroblastoma 12/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 09/2021
1	Leukemia 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Atopic Dermatitis (Atopic Eczema) 11/2018
1	Experimental Melanoma 05/2014
1	Metabolic Diseases (Metabolic Disease) 06/2012
1	Colonic Neoplasms (Colon Cancer) 04/2012
1	Carcinoma (Carcinomatosis) 06/2011

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 04/2020 - 09/2005
9	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 08/2009 - 09/2005
6	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2006
4	Biological ProductsIBA 12/2021 - 06/2011
3	muconomycin AIBA 09/2013 - 02/2013
3	LigandsIBA 05/2013 - 12/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 12/2011
3	NF-kappa B (NF-kB)IBA 04/2008 - 08/2005
2	FlavonoidsIBA 05/2022 - 12/2019
2	EnzymesIBA 01/2022 - 12/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2018
2	STK899704IBA 01/2018 - 01/2017
2	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2015 - 05/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2015 - 07/2012
2	TensinsIBA 09/2015 - 07/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2015 - 07/2012
1	kurarinoneIBA 05/2022
1	AcetylcholinesteraseIBA 01/2022
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2021
1	pipecolic acidIBA 01/2021
1	DepsipeptidesIBA 01/2021
1	Death Domain ReceptorsIBA 04/2020
1	beauvericinIBA 04/2020
1	streptimidoneIBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 12/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 12/2019
1	TransferasesIBA 05/2019
1	Decitabine FDA Link 05/2019
1	DNA (Deoxyribonucleic Acid)IBA 05/2019
1	Filaggrin ProteinsIBA 11/2018
1	Peptide Nucleic AcidsIBA 11/2018
1	Peptides (Polypeptides)IBA 10/2018
1	Angiogenesis InhibitorsIBA 03/2018
1	elaiophylinIBA 03/2018
1	Tubulin ModulatorsIBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Polo-Like Kinase 1IBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	eupafolinIBA 09/2015
1	pectate lyaseIBA 01/2015
1	brassininIBA 07/2014
1	Melanins (Melanin)IBA 05/2014
1	SesquiterpenesIBA 05/2014
1	1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA 05/2014
1	TrichothecenesIBA 09/2013
1	oligomycin AIBA 02/2013
1	salubrinalIBA 02/2013
1	TNF-Related Apoptosis-Inducing LigandIBA 02/2013
1	OligomycinsIBA 02/2013
1	4,4'- (3H,3'H- 5,5'- bibenzimidazole- 2,2'- diyl)dianilineIBA 01/2013
1	CamptothecinIBA 01/2013
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 01/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2012
1	Antineoplastic Agents (Antineoplastics)IBA 11/2012
1	geldanamycinIBA 11/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 07/2012
1	aloe emodinIBA 07/2012
1	DiketopiperazinesIBA 06/2012
1	Oxepins (Oxepin)IBA 06/2012
1	protuboxepin AIBA 06/2012
1	ginsenoside Rh2IBA 06/2012
1	Caspase 3 (Caspase-3)IBA 04/2012
1	PatulinIBA 04/2012
1	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 12/2011
1	asperlinIBA 06/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2011
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 05/2011
1	MitogensIBA 05/2011
1	TunicamycinIBA 05/2011
1	benzyloxycarbonyl- isoleucyl- glutamyl(O- tert- butyl)- alanyl- leucinalIBA 05/2011

Therapy/Procedure

16	Therapeutics 01/2020 - 08/2005
1	Immunotherapy 12/2019